Hereditary Cancer Testing
Inherited Cancer Risk Testing
Hereditary Cancer Testing is a genetic test that analyzes your DNA to identify inherited gene mutations that may increase your risk of developing certain cancers. This proactive approach supports early detection, personalized prevention strategies, and informed healthcare decisions-helping individuals and families manage cancer risk more effectively.
Key Features
Benefits of Hereditary Cancer Testing

Early Intervention & Prevention
Enables enhanced screening, risk-reducing measures, and early detection to improve long-term outcomes.

Informed Healthcare Decisions
Supports evidence-based choices related to screening frequency, preventive treatments, and, when appropriate, preventive surgeries.

Family Health Awareness
Helps relatives understand their own genetic risks and take proactive steps toward early detection and prevention.
Who Should Consider Hereditary Cancer Testing?
NIPT is recommended for expectant parents who may benefit from early genetic screening, including:
Individuals with a Family History of Cancer
Especially when multiple relatives are affected or cancers occur at a young age.
People with a Personal History of Cancer
Those seeking to determine whether genetic factors may have contributed to their diagnosis.
Individuals from Higher-Risk Ethnic Backgrounds
Certain populations have a higher prevalence of specific hereditary cancer syndromes.
Quick answers to common questions
What is Hereditary Cancer Testing?
Does having a cancer-related gene mutation mean I will develop cancer?
Who should consider Hereditary Cancer Testing?
How can my test results benefit my family members?
